1. |
中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南(2020年版). 中华结核和呼吸杂志, 2020, 43(12): 1023-1048.
|
2. |
中国医学科学院, 中国疾病预防控制中心, 中华预防医学会, 等. 中国慢性呼吸疾病流行状况与防治策略. 北京: 人民卫生出版社, 2018.
|
3. |
Bush A, Zar HJ. WHO universal definition of severe asthma. Curr Opin Allergy Clin Immunol, 2011, 11(2): 115-121.
|
4. |
何子凡, 高岩, 王晓玲, 等. NLRP3炎性小体在慢性阻塞性肺疾病患者机体炎症反应中作用的研究. 中国呼吸与危重监护杂志, 2018, 17(2): 119-123.
|
5. |
王兴兰, 张建勇. 冬凌草甲素对急性哮喘小鼠气道重塑的影响. 中医药临床杂志, 2022, 34(4): 715-721.
|
6. |
Colarusso C, Terlizzi M, Molino A, et al. Role of the inflammasome in chronic obstructive pulmonary disease (COPD). Oncotarget, 2017, 8(47): 81813-81824.
|
7. |
He Y, Hara H, G, Núñez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci, 2016, 41(12): 1012-1021.
|
8. |
Howrylak JA, Nakahira K. Inflammasomes: key mediators of lung immunity. Annu Review Physiol, 2017, 79(1): 471-494.
|
9. |
邹进晶, 陈国忠. NLRP3炎性小体在慢性气道炎症性疾病中的作用研究进展. 解放军医学杂志, 2022, 47(3): 286-291.
|
10. |
Kim K, Kim HJ, Binas B, et al. Inflammatory mediators ATP and S100A12 activate the NLRP3 inflammasome to induce MUC5AC production in airway epithelial cells. Biochem Biophys Res Commun, 2018, 503(2): 657-664.
|
11. |
Tan HT, Hagner S, Ruchti F, et al. Tight junction, mucin, and inflammasome-related molecules are differentially expressed in eosinophilic, mixed, and neutrophilic experimental asthma in mice. Allergy, 2019, 74(2): 294-307.
|
12. |
惠超, 刘馨. NOD样受体热蛋白结构域相关蛋白3对哮喘小鼠气道炎症反应及细胞焦亡的调控作用. 中国当代儿科杂志, 2021, 23(9): 959-964.
|
13. |
彭菲菲, 邵强, 赵宁, 等. MCC950对线粒体损伤相关分子模式诱导大鼠肺损伤的保护作用. 医学研究生学报, 2017, 30(11): 1166-1171.
|
14. |
Xu KY, Wu CY, Tong S, et al. The selective Nlrp3 inflammasome inhibitor Mcc950 attenuates lung ischemia - reperfusion injury. Biochem Biophys Res Commun, 2018, 503(4): 3031-3037.
|
15. |
蒋陈, 高佳, 张磊, 等. MCC950对脂多糖诱导小鼠急性肺损伤的保护作用. 中国急救医学, 2020, 40(10): 981-985.
|
16. |
宋占帅, 邵华, 陈艳芹, 等. NLRP3在矽肺肺纤维化发生发展中的作用及MCC950应用研究. 中国职业医学, 2018, 45(6): 691-696.
|
17. |
Tate MD, Ong JD, Dowling JK, et al. Reas-sessing the role of the NLRP3 inflammasome during pathogenic influenza A virus infection via temporal inhibition. Sci Rep, 2016, 6: 27912.
|
18. |
Jia XH, Liu B, Bao LL, et al. Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration. PLos Pathog, 2018, 14: e1007428.
|
19. |
Chen SY, Yao LH, Huang PK, et al. Blockade of the NLRP3/caspase-1 axis ameliorates airway neutrophilic inflammation in a toluene diisocyanate-induced murine asthma model. Toxicol Sci, 2019, 170(2): 462-475.
|
20. |
Hu XY, Shen YC, Zhao YL, et al. Epithelial aryl hydrocarbon receptor protects from mucus production by inhibiting ROS-triggered NLRP3 inflammasome in asthma. Front Immunol, 2021, 12: 767508.
|
21. |
Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol, 2019, 19(8): 477-489.
|